Publication|Videos|April 19, 2024

Interview with Hayley Crowe, Executive VP & GM at Ecolab Global Life Sciences

Author(s)Purolite, Ecolab

Hayley Crowe, Executive VP & GM at Ecolab Global Life Sciences, talks about the company's services and how they relate to trends in bioprocessing and purification.

Key Learning Objectives:

  • Learn more about Ecolab’s new Life Sciences Sector and Ecolab’s investment into additional supply capacity globally.
  • Learn more about Purolite’s bioprocessing division and unique technologies.
  • Understand how Purolite is addressing key challenges and trends in bioprocessing purification.


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.